SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:gup.ub.gu.se/301008"
 

Search: id:"swepub:oai:gup.ub.gu.se/301008" > Correlation of Body...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 Enzymes

Krogstad, V. (author)
Peric, A. (author)
Robertsen, I. (author)
show more...
Kringen, M. K. (author)
Vistnes, M. (author)
Hjelmesaeth, J. (author)
Sandbu, R. (author)
Johnson, L. K. (author)
Angeles, P. C. (author)
Jansson-Lofmark, R. (author)
Karlsson, Cecilia, 1968 (author)
Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine
Andersson, S. (author)
Asberg, A. (author)
Andersson, T. B. (author)
Christensen, H. (author)
show less...
 (creator_code:org_t)
Elsevier BV, 2021
2021
English.
In: Journal of Pharmaceutical Sciences. - : Elsevier BV. - 0022-3549 .- 1520-6017. ; 110:1, s. 432-437
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Obesity is associated with comorbidities of which pharmacological treatment is needed. Physiological changes associated with obesity may influence the pharmacokinetics of drugs, but the effect of body weight on drug metabolism capacity remains uncertain. The aim of this study was to investigate ex vivo activities of hepatic drug metabolizing CYP enzymes in patients covering a wide range of body weight. Liver biopsies from 36 individuals with a body mass index (BMI) ranging from 18 to 63 kg/m(2) were obtained. Individual hepatic microsomes were prepared and activities of CYP3A, CYP2B6, CYP2C8, CYP2D6, CYP2C9, CYP2C19 and CYP1A2 were determined. The unbound intrinsic clearance (C-Lint,C-u) values for CYP3A correlated negatively with body weight (r = -0.43, p < 0.01), waist circumference (r = -0.47, p < 0.01), hip circumference (r = -0.51, p < 0.01), fat percent (r = -0.41, p < 0.05), fat mass (r = -0.48, p < 0.01) and BMI (r = -0.46, p < 0.01). Linear regression analysis showed that C-Lint,C-u values for CYP3A decreased with 5% with each 10% increase in body weight (r(2) = 0.12, beta = -0.558, p < 0.05). There were no correlations between body weight measures and CLint,u values for the other CYP enzymes investigated. These results indicate reduced hepatic metabolizing capacity of CYP3A substrates in patients with increasing body weight. (C) 2020 The Authors. Published by Elsevier Inc.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)

Keyword

Cytochrome P450 (CYP)
Drug metabolizing enzyme(s)
First-pass
metabolism
Hepatic metabolism
Human liver microsomes
Phase I
metabolism
consortium cpic guidelines
morbidly obese-patients
cyp3a4 expression
pharmacokinetics
midazolam
liver
epidemiology
disposition
cytokines
impact
Pharmacology & Pharmacy
Chemistry

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view